Wanbangde Pharmaceutical Holding Group Co.,Ltd.’s Net Profit Dropped 42.1% in First Half of 2023

Wanbangde Pharmaceutical Holding Group Co.,Ltd. (万邦德医药控股集团股份有限公司) (002082.SZ) reported a net profit of 29.7 million yuan in the first half of 2023, down 42.1% year-on-year.

Meanwhile, the company posted 738.6 million yuan in revenue, up 1% year-on-year.

At the end of the reporting period, it had 4.4 billion yuan in total assets and 1.6 billion yuan in total liabilities, with a liability-to-asset ratio of 36.7%.